We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


OGT to Unveil Sequencing Offering at ESHG 2011

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "OGT to Unveil Sequencing Offering at ESHG 2011"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Oxford Gene Technology (OGT), will host a workshop at this year’s European Society of Human Genetics (ESHG) conference in Amsterdam.

The workshop, entitled “Adding value through analysis”, will take place on Saturday the 28th of May and will reveal details of OGT’s new comprehensive targeted sequencing service.

Hosted between 11:45 and 13:15 in room E104-105 of the Congress Centre, the seminar will feature presentations from OGT team members including Chief Executive Officer Mike Evans, DPhil, Senior Computational Biologist Jolyon Holdstock, PhD and Head of Computational Biology Volker Brenner, PhD. Each talk will focus on key elements of the new service, culminating in an informal discussion over lunch provided by OGT.

The sheer volume of data generated by next generation sequencing can present a serious obstacle to researchers in terms of data management, storage and analysis.

To address this challenge, OGT’s targeted sequencing service is designed to provide meaningful results rather than insurmountable data sets, achieved by utilizing OGT’s internationally recognized probe design and data analysis expertise plus independently accredited quality control procedures.

The sequencing options available combine seamlessly with other aspects of OGT’s Genefficiency™ genomic services offering to provide the most flexible and powerful solution available for driving your genomic research forward.